EQUITY (Tables)

6 Months Ended

Jun. 30, 2024

Equity

Schedule of issued capital

	December 31,		June 30,
	2023		2024		2024
	CNY		CNY		US$
	(Audited)		(Unaudited)		(Unaudited)
Preferred shares authorized: June 30, 2024: 10,000,000, (December 31, 2023: 10,000,000) preferred shares, no par value
Preferred shares issued and fully issued paid: June 30, 2024: Nil, (December 31, 2023: Nil) preferred shares, no par value		—		—		—
Common shares authorized: June 30, 2024: 200,000,000, (December 31, 2023: 200,000,000) common shares, no par value
Common shares issued and fully paid:
June 30, 2024: 9,865,767*, (December 31, 2023: 8,377,897) common shares, no par value		450,782		450,782		62,029

Schedule of issued capital shares combination

	Number of shares			Share capital
				CNY		US$
As of January 1, 2023		40,948,082			450,782		62,029
Effect of Five-to-One Share Combination		(32,750,185	)		—		—
Equity-settled share-based payments		180,000			—		—
As of December 31, 2023 and January 1, 2024		8,377,897			450,782		62,029
Common shares issued through private placement*		1,487,870			—		—
As of June 30, 2024		9,865,767			450,782		62,029

* On February 16, 2024, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company agreed to issue and sell, (i) in a registered direct offering, up to an aggregate of 1,487,870 of common shares with no par value of the Company at a per share purchase price of US$2.20 (the “Registered Offering”), and (ii) in a concurrent private placement, warrants initially exercisable for the purchase of an aggregate of 1,115,903 common shares of the Company at an exercise price of $3.00 per share. The registered Offering was closed on February 21, 2024.